Antitumor Activity of Tasurgratinib as an Orally Available FGFR1-3 Inhibitor in Cholangiocarcinoma Models With FGFR2-fusion
-
Published:2024-05-31
Issue:6
Volume:44
Page:2393-2406
-
ISSN:0250-7005
-
Container-title:Anticancer Research
-
language:en
-
Short-container-title:Anticancer Res
Author:
KAWANO SATOSHI,KAWADA MEGUMI IKEMORI,FUKUSHIMA SAYO,ARAI YASUHITO,SHIBATA TATSUHIRO,MIYANO SAORI WATANABE
Publisher
Anticancer Research USA Inc.